Guardant Health
88 hedge funds and large institutions have $2.32B invested in Guardant Health in 2018 Q4 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
71.96% more ownership
Funds ownership: 0% → 71.96% (+72%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
+$951M |
| 2 |
SUT
SC US (TTGP)
Menlo Park,
California
|
+$287M |
| 3 |
Morgan Stanley
New York
|
+$77.9M |
| 4 |
SoftBank Group
Tokyo,
Japan
|
+$74.9M |
| 5 |
Temasek Holdings
Singapore
|
+$59.4M |
Top Sellers
GH Hedge Fund Activity: Q4 2018 in Review
88 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2018, worth a combined $2.32B.
Buyers outnumbered sellers: 88 funds opened new GH positions and 0 closed out — a net gain of 88 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was SB Investment Advisers (UK), opening a new position worth an estimated $951M.
- 88 institutional investors held Guardant Health (GH) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $2.32B of Guardant Health stock for Q4 2018.
- 88 funds opened new Guardant Health positions in Q4 2018 and 0 closed out, a net change of +88 holders.
- The largest Guardant Health buyer in Q4 2018 was SB Investment Advisers (UK), an estimated $951M added.
Based on aggregated 13F filings for Q4 2018.